GLOW Stack vs Superman Stack
A side-by-side research comparison of GLOW Stack and Superman Stack across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | GLOW Stack | Superman Stack |
|---|---|---|
| Full name | GLOW (GHK-Cu + BPC-157 + TB-500) | Superman (CJC-1295 + Ipamorelin + MK-677) |
| Category | Popular Stacks | Popular Stacks |
| Status | Research stack | Research stack |
| Mechanism | GHK-Cu activates collagen synthesis, attracts immune and stem cells to damaged tissue, remodels the extracellular matrix, and provides potent antioxidant protection. BPC-157 promotes angiogenesis and upregulates VEGF for tissue repair. TB-500 upregulates actin to enhance cell migration and reduces pro-inflammatory cytokines for systemic healing. | CJC-1295 (no DAC) mimics GHRH for pituitary stimulation. Ipamorelin acts as a selective ghrelin receptor agonist for GH release without cortisol/prolactin. MK-677 provides oral, long-acting ghrelin mimetic action for sustained IGF-1 elevation. |
| Molecular weight | Multiple compounds | Multiple compounds |
| Half-life | GHK-Cu: ~2h, BPC-157: ~4h, TB-500: ~6h | CJC: ~30min, Ipamorelin: ~2h, MK-677: ~24h |
| Bioavailability | All ~95% via subcutaneous injection | CJC/Ipa: ~95% SC, MK-677: ~60% oral |
| Typical dose | GHK-Cu 200mcg + BPC-157 500mcg + TB-500 2.5mg | CJC-1295 100mcg + Ipamorelin 200mcg + MK-677 25mg oral |
| Frequency | GHK-Cu & BPC-157 daily · TB-500 2-3x/week | CJC/Ipa: nightly, MK-677: daily |
| Route | Subcutaneous injection | Subcutaneous + Oral |
GLOW Stack reported benefits
- Skin rejuvenation & collagen production
- Reduced inflammation
- Accelerated wound healing
- Hair and nail improvement
- Anti-aging at cellular level
- Connective tissue repair
Superman Stack reported benefits
- Maximized GH output
- 24/7 GH/IGF-1 elevation
- Improved sleep quality
- Enhanced fat loss
- Increased muscle recovery
- Anti-aging effects
Related comparisons
Research and educational reference only. Not medical advice.